EMERGENT BIOSOLUTION EBS (NYSE)

$ 13.74
17:39
Change: unch (unch%)
Volume: 184,596

Avg. Volume: 248335
P/E Ratio: 10
EPS (Annual): 1.33
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 29,750
Institutional Shareholders: 28.39%
Last: 13.74
Change: unch (unch%)
Prev. Close: 13.74
Open: 13.79
Day's Range: 13.56 - 14.05
52wk Range: 4.40 - 14.39
Market Value: 414,050
Beta:
12-month EPS Change: 0.00%
Total Return Last 12 Months: +59.77%
Total Return Last 3 Years: +23.72%
Total Return Last 5 Years: +17.44%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on EBS

Emergent gets $24.3 million for anthrax treatment

(ROCKVILLE, Md.)Biotech company Emergent Biosolutions said Wednesday it received a $24.3 million contract to continue development of its experimental anthrax treatment.READ MORE
Sep 03, 2008 4:01PM
Keywords: EBS

Emergent Biosolutions spent $560K lobbying in 2Q

(WASHINGTON)Biopharmaceutical company Emergent BioSolutions Inc. spent $560,000 lobbying the federal government in the second quarter, according to a recent disclosure form.READ MORE
Aug 13, 2008 2:01PM
Keywords: EBS

Earnings roundup: Key Energy, Osiris

Among the earnings stories for Thursday, Aug. 7, from AP Financial News: HOUSTON (AP)--Shares of Key Energy Services Inc. wavered Thursday after the oil drilling services company s...READ MORE
Aug 07, 2008 6:12PM
Keywords: KEG, OSIR, POR, EBS

Emergent BioSolutions shares plunge on outlook

(ROCKVILLE, Md.)Emergent BioSolutions Inc. said Thursday it swung to a second-quarter profit on higher sales of its anthrax vaccine BioThrax. But, shares plunged as the company said it will likely...READ MORE
Aug 07, 2008 2:02PM
Keywords: EBS

Protein Sciences, Emergent spar over merger deal

(MERIDEN, Conn.)Privately held Protein Sciences Corp. on Tuesday said it will not sell to fellow biotechnology company Emergent BioSolutions Inc., citing breaches of the buyout agreement, but Emer...READ MORE
Jul 29, 2008 4:37PM
Keywords: EBS

Emergent Biosolutions spent $550K lobbying in 1Q

(WASHINGTON)Biopharmaceutical company Emergent BioSolutions Inc. spent $550,000 lobbying in the first quarter, according to a recent disclosure form. Emergent BioSolutions lobbied on the gover...READ MORE
Jun 27, 2008 3:26PM
Keywords: EBS

Emergent buying Protein Sciences Corp. in $78M deal

(NEW YORK)Biopharmaceutical company Emergent BioSolutions Inc. said Tuesday that it would acquire vaccine maker Protein Sciences Corp. in a deal worth up to $78 million.READ MORE
May 27, 2008 9:02AM
Keywords: EBS
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN +30.20 60.88
AMYLIN PHARMA I -55.90 21.48
GILEAD SCIENCES +22.60 49.98
BIOGEN IDEC INC -21.40 48.16
GENENTECH INC +33.70 96.50